REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Everest Medicines Limited (Hong Kong) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Everest Medicines Limited Profile Updated: October 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Everest Medicines Limited focuses on the research and development of drugs for the treatment of tumor, immune, heart and kidney diseases and infectious diseases. The company offers a portfolio of clinical phase drug candidates. The company was established in 2017 and headquartered in Shanghai City, China.

Headquarters
Plaza 66, Tower 1, Units 6601-6606, 1266 West Nanjing Road
Shanghai; Shanghai; Postal Code: 200040

Contact Details: Purchase the Everest Medicines Limited (Hong Kong) report to view the information.

Basic Information
Total Employees:
Purchase the Everest Medicines Limited (Hong Kong) report to view the information.
Outstanding Shares:
Purchase the Everest Medicines Limited (Hong Kong) report to view the information.
Registered Capital:
Purchase the Everest Medicines Limited (Hong Kong) report to view the information.
Financial Auditors:
Purchase the Everest Medicines Limited (Hong Kong) report to view the information.
Incorporation Date:
July 14, 2017
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
39.75%
Purchase this report to view the information.
15.38%
Purchase this report to view the information.
11.45%
Purchase this report to view the information.
6.78%
Purchase this report to view the information.
Subsidiaries
Everest Medicines (Singapore) Pte. Limited (Singapore)
100%
Everest Medicines Ii Limited (United Kingdom)
100%
Everstar Medicine (Us) Limited (United States)
100%
Company Performance
Financial values in the chart are available after Everest Medicines Limited (Hong Kong) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
3289.74%▲
Total operating revenue
2674.75%▲
Operating profit (EBIT)
-41.9%▼
EBITDA
37.28%▲
Net Profit (Loss) for the Period
-49.29%▼
Total assets
-12.15%▼
Total equity
-18.55%▼
Operating Profit Margin (ROS)
5216.26%▲
Net Profit Margin
4552.62%▲
Return on Equity (ROE)
-6.52%▼
Debt to Equity Ratio
6.74%▲
Quick Ratio
-11.16%▼
Cash Ratio
-13.97%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo